サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1597172

欧州の臨床リファレンスラボ市場：2031年までの予測 - 地域別分析 - サービスプロバイダー別、用途別

Europe Clinical Reference Laboratory Market Forecast to 2031 - Regional Analysis - by Service Provider (Hospital-Based, Standalone, and Clinic-Based) and Application (Laboratory Medicine, Clinical Trials, and Others)

出版日
ページ情報
英文 103 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.42円
欧州の臨床リファレンスラボ市場：2031年までの予測 - 地域別分析 - サービスプロバイダー別、用途別
出版日: 2024年10月03日
発行: The Insight Partners
ページ情報: 英文 103 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の臨床リファレンスラボ市場は、2023年に134億3,117万米ドルと評価され、2031年には216億7,000万米ドルに達すると予測され、2023年から2031年までのCAGRは6.2%と推定されます。

臨床試験数の増加が欧州の臨床リファレンスラボ市場を牽引

臨床試験は、新薬、食事療法、医療技術などの新しい治療法や予防法が安全で効果的かどうかを評価するのに役立ちます。臨床試験は主に医薬品開発段階で実施されます。欧州医薬品庁によると、欧州連合（EU）では年間約4,000件の臨床試験が承認されており、製薬業界がその約60％を占めています。慢性疾患の増加により、様々な有効な治療法を開発するために臨床試験の数が増加しています。臨床試験は徐々に複雑な手順になってきており、研究ベースの組織で行われる業務の適切な実行と監視が重要になってきています。研究開発機関では、不適切な実施によるミスを避けるため、製品開発と同時に臨床試験をアウトソーシングしています。リファレンスラボは、科学技術の進歩に対応するための積極的なアプローチでよく知られています。リファレンスラボは、新しい診断機器、装置、技術を迅速に導入し、統合することで、その潜在的な用途と利点を評価することができます。臨床リファレンスラボは、安価で効率的に実施される臨床リファレンスラボおよび比較検査の包括的なメニューを提供することで、研究チームがプロジェクトを成功させるのを支援します。クリニカルリファレンスラボは、必要なサンプルを収集・提供し、その施設で必要な検査を実施します。つまり、すべてのサービスが一つ屋根の下で利用可能なのです。Vimta Labs Ltd、Regional Pathology Services、Boca Bioは商業的臨床試験サービスを提供しています。このように、臨床試験の増加が臨床リファレンスラボ薬市場の成長を牽引しています。

欧州臨床リファレンスラボ市場概要

ドイツでは、がん、心血管疾患、神経系疾患、感染症が臨床試験で最も頻繁に研究される疾患です。臨床研究は、ドイツの確立された交通、通信、エネルギー、公共サービスのインフラから恩恵を受けています。国立衛生研究所が2023年12月に発表した論文によると、ドイツでは400万人以上が希少疾患に罹患しています。希少疾患には複雑な臨床パターンがあります。このような疾患の治療には、迅速な臨床試験と迅速な臨床結果が必要です。そこでリファレンスラボが重要な役割を果たします。2023年1月、Premier ResearchはCENTOGENEと提携し、希少疾患の臨床開発のリスクを軽減しました。プレミア・リサーチの希少疾患製品開発における広範な専門知識は、セントジーンのバイオデータバンクとマルチオミクス・リファレンスラボラトリーによって生み出される高度な知見によってサポートされます。さらに、ドイツにおける抗感染症薬の需要は、慢性的なウイルス性疾患の有病率の増加や、満たされていない条件を満たすためにウイルス性治療領域向けの新しい分子を製造する需要が高まっていることに起因して、大きく伸びています。上記の要因により、同国の市場は大きく成長すると予想されます。

欧州の臨床リファレンスラボ市場の収益と2031年までの予測（金額）

欧州の臨床リファレンスラボ市場セグメンテーション

欧州の臨床リファレンスラボ市場は、サービスプロバイダー、用途、国に分類されます。

サービスプロバイダーに基づき、欧州の臨床リファレンスラボ市場は病院ベース、スタンドアロン、クリニックベースに区分されます。病院ベースのセグメントが2023年に最大の市場シェアを占めました。

用途別では、欧州の臨床リファレンスラボ市場は検査薬、臨床試験、その他に分類されます。2023年には臨床リファレンスラボ部門が最大の市場シェアを占めました。

国別では、欧州臨床リファレンスラボ市場はドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。2023年の欧州臨床リファレンスラボ市場シェアはドイツが独占。

Sonic Healthcare Ltd、UNILABS、Laboratory Corp of America Holdings、Quest Diagnostics Inc、SYNLAB International GmbH、Myraid Genetics Incは、欧州臨床リファレンスラボ市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 欧州主要洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州臨床リファレンスラボ市場- 主要市場力学

  • 市場促進要因
    • 慢性疾患および感染症の有病率の上昇
    • 臨床試験数の増加
  • 市場抑制要因
    • 規制の枠組みや継続的な技術開発の採用に関する複雑さ
  • 市場機会
    • リファレンスラボとの戦略的イニシアティブ
  • 今後の動向
    • 臨床リファレンスラボにおける人工知能の利用
  • 促進要因と抑制要因の影響

第5章 臨床リファレンスラボ市場：欧州分析

  • 臨床リファレンスラボ市場の収益、2021-2031年
  • 臨床リファレンスラボ市場の予測と分析

第6章 欧州臨床リファレンスラボ市場分析：サービスプロバイダー別

  • 病院
  • 独立型
  • クリニック

第7章 欧州の臨床リファレンスラボ市場分析：用途別

  • 臨床検査
  • 臨床試験
  • その他

第8章 欧州臨床リファレンスラボ市場：国別分析

    • 欧州
      • ドイツ
      • 英国
      • フランス
      • イタリア
      • スペイン
      • その他欧州

第9章 臨床リファレンスラボ市場-業界情勢

  • 臨床リファレンスラボ市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第10章 企業プロファイル

  • Sonic Healthcare Ltd
  • UNILABS
  • Laboratory Corp of America Holdings
  • Quest Diagnostics Inc
  • SYNLAB International GmbH
  • Myraid Genetics Inc

第11章 付録

図表

List Of Tables

  • Table 1. Europe Clinical Reference Laboratory Market Segmentation
  • Table 2. Clinical Reference Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. Germany: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
  • Table 4. Germany: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 5. United Kingdom: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
  • Table 6. United Kingdom: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 7. France: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
  • Table 8. France: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 9. Italy: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
  • Table 10. Italy: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 11. Spain: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
  • Table 12. Spain: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 13. Rest of Europe: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
  • Table 14. Rest of Europe: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 15. Recent Inorganic Growth Strategies in the Clinical Reference Laboratory Market
  • Table 16. Recent Organic Growth Strategies in the Clinical Reference Laboratory Market
  • Table 17. Glossary of Terms

List Of Figures

  • Figure 1. Europe Clinical Reference Laboratory Market Segmentation, by Country
  • Figure 2. Clinical Reference Laboratory Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Clinical Reference Laboratory Market Revenue (US$ Million), 2021-2031
  • Figure 5. Clinical Reference Laboratory Market Share (%) - by Service Provider (2023 and 2031)
  • Figure 6. Hospital-Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Standalone: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Clinical Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Clinical Reference Laboratory Market Share (%) - by Application (2023 and 2031)
  • Figure 10. Laboratory Medicine: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Clinical Trials: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Others: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Europe: Clinical Reference Laboratory Market, by Key Country - Revenue (2023) (US$ Million)
  • Figure 14. Europe: Clinical Reference Laboratory Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 15. Germany: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. United Kingdom: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. France: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Italy: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Spain: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Rest of Europe: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Growth Strategies in the Clinical Reference Laboratory Market
目次
Product Code: BMIRE00030829

The Europe clinical reference laboratory market was valued at US$ 13,431.17 million in 2023 and is expected to reach US$ 21,670.00 million by 2031; it is estimated to register a CAGR of 6.2% from 2023 to 2031.

Increasing Number of Clinical Trials Drives Europe Clinical Reference Laboratory Market

Clinical trials assist in evaluating whether a new treatment or prevention method, such as a new medicine, diet, or medical technology, is safe and effective. The trials are primarily conducted during the drug development phase. According to the European Medicine Agency, in the European Union (EU), ~4,000 clinical trials are approved annually, with the pharmaceutical industry accounting for roughly 60%. Due to the growing prevalence of chronic diseases, the number of clinical trials is increasing to develop various effective treatments. Clinical trials are gradually becoming complex procedures, because proper execution and oversight of the operations occurring in research-based organizations have become crucial. Research-based organizations are outsourcing clinical trials while developing their products to avoid errors due to improper execution. Reference laboratories are well-known for their proactive approach to keeping up with scientific and technological advancements. Reference labs promptly adopt and integrate new diagnostic instruments, equipment, and techniques, allowing them to evaluate their potential applications and benefits. Clinical reference labs help research teams successfully conduct their projects by providing a comprehensive menu of clinical and comparative testing performed inexpensively and efficiently. Clinical reference labs collect and provide the required samples and perform the necessary testing at their facility. That means all the services are available under one roof. Vimta Labs Ltd, Regional Pathology Services, and Boca Bio provide commercial clinical trial services. Thus, the increasing number of clinical trials is driving the clinical reference laboratory market growth.

Europe Clinical Reference Laboratory Market Overview

Cancer, cardiovascular illness, nervous system disorders, and infectious diseases are the most frequently studied conditions in clinical trials in Germany. Clinical research benefits from Germany's well-established transport, communication, energy, and public services infrastructure. According to an article published by the National Institutes of Health in December 2023, ~4 million people had a rare disease in Germany. Rare diseases have complex clinical patterns. Treatments for such diseases need accelerated trials and fast-track clinical outcomes. This is where reference laboratories play a crucial role. In January 2023, Premier Research partnered with CENTOGENE to de-risk rare disease clinical development. Premier Research's extensive expertise in rare disease product development will be supported by advanced insights generated by the CENTOGENE Biodatabank and multiomic reference laboratories. Moreover, the demand for anti-infective agents in Germany is growing significantly, attributed to the increasing prevalence of chronic viral diseases and the growing demand to produce new molecules for viral therapeutic areas to fulfill unmet conditions. The market is expected to grow significantly in the country due to the abovementioned factors.

Europe Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million)

Europe Clinical Reference Laboratory Market Segmentation

The Europe clinical reference laboratory market is categorized into service provider, application, and country.

Based on service provider, the Europe clinical reference laboratory market is segmented into hospital-based, standalone, and clinic-based. The hospital-based segment held the largest market share in 2023.

In terms of application, the Europe clinical reference laboratory market is categorized into laboratory medicine, clinical trials, and others. The laboratory medicine segment held the largest market share in 2023.

By country, the Europe clinical reference laboratory market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe clinical reference laboratory market share in 2023.

Sonic Healthcare Ltd, UNILABS, Laboratory Corp of America Holdings, Quest Diagnostics Inc, SYNLAB International GmbH, and Myraid Genetics Inc are some of the leading companies operating in the Europe clinical reference laboratory market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Europe Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Clinical Reference Laboratory Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Prevalence of Chronic and Infectious Diseases
    • 4.1.2 Increasing Number of Clinical Trials
  • 4.2 Market Restraints
    • 4.2.1 Complications Related to Regulatory Framework and Adoption of Continuous Technological Developments
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives with Reference Laboratories
  • 4.4 Future Trends
    • 4.4.1 Use of Artificial Intelligence in Clinical Reference Laboratories
  • 4.5 Impact of Drivers and Restraints:

5. Clinical Reference Laboratory Market - Europe Analysis

  • 5.1 Clinical Reference Laboratory Market Revenue (US$ Million), 2021-2031
  • 5.2 Clinical Reference Market Forecast and Analysis

6. Europe Clinical Reference Laboratory Market Analysis - by Service Provider

  • 6.1 Overview
  • 6.2 Hospital-Based
    • 6.2.1 Overview
    • 6.2.2 Hospital-Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Standalone
    • 6.3.1 Overview
    • 6.3.2 Standalone: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.4 Clinical Based
    • 6.4.1 Overview
    • 6.4.2 Clinical Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)

7. Europe Clinical Reference Laboratory Market Analysis - by Application

  • 7.1 Overview
  • 7.2 Laboratory Medicine
    • 7.2.1 Overview
    • 7.2.2 Laboratory Medicine: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Clinical Trials
    • 7.3.1 Overview
    • 7.3.2 Clinical Trials: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Clinical Reference Laboratory Market - Country Analysis

  • 8.1 Europe Clinical Reference Laboratory Market Overview
    • 8.1.1 Europe: Clinical Reference Laboratory Market Breakdown 2023 and 2031 (%) - by Country
      • 8.1.1.1 Germany: Clinical Reference Laboratory Market - Overview
      • 8.1.1.2 Germany: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.2.1 Germany: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
        • 8.1.1.2.2 Germany: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
      • 8.1.1.3 United Kingdom: Clinical Reference Laboratory Market - Overview
      • 8.1.1.4 United Kingdom: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.4.1 United Kingdom: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
        • 8.1.1.4.2 United Kingdom: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
      • 8.1.1.5 France: Clinical Reference Laboratory Market - Overview
      • 8.1.1.6 France: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.6.1 France: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
        • 8.1.1.6.2 France: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
      • 8.1.1.7 Italy: Clinical Reference Laboratory Market - Overview
      • 8.1.1.8 Italy: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.8.1 Italy: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
        • 8.1.1.8.2 Italy: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
      • 8.1.1.9 Spain: Clinical Reference Laboratory Market - Overview
      • 8.1.1.10 Spain: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.10.1 Spain: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
        • 8.1.1.10.2 Spain: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
      • 8.1.1.11 Rest of Europe: Clinical Reference Laboratory Market - Overview
      • 8.1.1.12 Rest of Europe: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.12.1 Rest of Europe: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
        • 8.1.1.12.2 Rest of Europe: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application

9. Clinical Reference Laboratory Market-Industry Landscape

  • 9.1 Overview
  • 9.2 Growth Strategies in the Clinical Reference Laboratory Market
  • 9.3 Inorganic Growth Strategies
    • 9.3.1 Overview
  • 9.4 Organic Growth Strategies
    • 9.4.1 Overview

10. Company Profiles

  • 10.1 Sonic Healthcare Ltd
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 UNILABS
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Laboratory Corp of America Holdings
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Quest Diagnostics Inc
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 SYNLAB International GmbH
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Myraid Genetics Inc
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners
  • 11.2 Glossary of Terms